| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2140934 | Lung Cancer | 2014 | 5 Pages |
Abstract
Sorafenib monotherapy did not achieve positive result in patients defined in our trial and we need better biomarker to determine the population who can benefit from sorafenib treatment (ClinicalTrials.gov number: NCT00922584).
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Qing Zhou, Cai-cun Zhou, Gong-yan Chen, Ying Cheng, Cheng Huang, Li Zhang, Chong-rui Xu, Ai-wu Li, Hong-hong Yan, Jian Su, Xu-chao Zhang, Jin-ji Yang, Yi-long Wu,